elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27612411-CED78BDA-4DA1-4EEC-8F30-759441ED6E4B
Q27612411-CED78BDA-4DA1-4EEC-8F30-759441ED6E4B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27612411-CED78BDA-4DA1-4EEC-8F30-759441ED6E4B
CIViC database
P2860
Q27612411-CED78BDA-4DA1-4EEC-8F30-759441ED6E4B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27612411-CED78BDA-4DA1-4EEC-8F30-759441ED6E4B
rank
NormalRank
type
BestRank
Statement
P2860
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.